Deptbiochemistry00ruttrich.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Deptbiochemistry00ruttrich.Pdf 'Berkeley University o'f California Regional Oral History Office UCSF Oral History Program The Bancroft Library Department of the History of Health Sciences University of California, Berkeley University of California, San Francisco The UCSF Oral History Program and The Program in the History of the Biological Sciences and Biotechnology William J. Rutter, Ph.D. THE DEPARTMENT OF BIOCHEMISTRY AND THE MOLECULAR APPROACH TO BIOMEDICINE AT THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO VOLUME I With an Introduction by Lloyd H. Smith, Jr., M.D. Interviews by Sally Smith Hughes, Ph.D. in 1992 Copyright O 1998 by the Regents of the University of California Since 1954 the Regional Oral History Office has been interviewing leading participants in or well-placed witnesses to major events in the development of Northern California, the West, and the Nation. Oral history is a method of collecting historical information through tape-recorded interviews between a narrator with firsthand knowledge of historically significant events and a well- informed interviewer, with the goal of preserving substantive additions to the historical record. The tape recording is transcribed, lightly edited for continuity and clarity, and reviewed by the interviewee. The corrected manuscript is indexed, bound with photographs and illustrative materials, and placed in The Bancroft Library at the University of California, Berkeley, and in other research collections for scholarly use. Because it is primary material, oral history is not intended to present the final, verified, or complete narrative of events. It is a spoken account, offered by the interviewee in response to questioning, and as such it is reflective, partisan, deeply involved, and irreplaceable. ************************************ All uses of this manuscript are covered by a legal agreement between the Regents of the University of California and William J. Rutter, dated November 8, 1992. The manuscript is thereby made available for research purposes. All literary rights in the manuscript, including the right to publish, are reserved to the UCSF Library and Center for Knowledge Management, and The Bancroft Library of the University of California, Berkeley. No part of the manuscript may be quoted for publication without the written permission of the Head, Archives and Special Collections, UCSF Library and Center for Knowledge Management or the Director, The Bancroft Library. Requests for permission to quote for publication should be addressed to the Head, Archives and Special Collections, UCSF Library and Center for Knowledge Management, or the Director, The Bancroft Library, and should include identification of the specific passages to be quoted, anticipated use of the passages, and identification of the user. The legal agreement with William J. Rutter requires that he be notified of the request and allowed thirty days in which to respond. It is recommended that this oral history be cited as follows: William J. Rutter, Ph.D., "The Department of Biochemistry and the Molecular Approach to Biomedicine at the University of California, San Francisco," Volume I, an oral history conducted in 1992 by Sally Smith Hughes, Ph.D., Regional Oral History Office, The Bancroft Library, University of California, Berkeley, 1998. Copy no. \ - William J. Rutter. Cataloguing information RUTTER, William J. (b. 1928) Biochemist-biotechnologist The Department of Biochemistry and the Molecular Approach to Biomedicine at the University of California. San Francisco. Volume I of II, 1998, vi, 237 pp. Education; early career at universities of Illinois, Stanford, and Washington; research on galactosemia, aldolase, RNA polymerase, pancreatic differentiation; Department of Biochemistry and Biophysics, University of California, San Francisco [UCSF] : recruitment, development of department, introducing molecular approach, administrative and science strategy, collaboration and competition; director, Hormone Research Institute, UCSF; UCSF role in early biotechnology industry; Genentech; rat and human insulin gene projects; recombinant DNA controversy; biosafety; pBR322 plasmid episode; hepatitis B vaccine; commercialization of basic academic sciences; intellectual property; Gordon Tomkins; Howard Goodman; Axel Ullrich. Introduction by Lloyd H. Smith, Jr., M.D., Associate Dean, UCSF School of Medicine. Interviewed 1992 by Sally Smith Hughes for the UCSF Oral History Program, Department of the History of Health Sciences, University of California, San Francisco, and the Program in the History of the Biological Sciences and Biotechnology, Regional Oral History Office, The Bancroft Library, University of California, Berkeley. TABLE OF CONTENTS--William J. Rutter - PREFACE i INTRODUCTION by Lloyd H. Smith, Jr., M.D. ii INTERVIEW HISTORY vi BIOGRAPHICAL INFORMATION x I EDUCATION AND EARLY CAREER 1 Early Education 1 Doctoral Student, University of Illinois 3 The Decision to Study Biochemistry 3 Postdoctoral Fellow, University of Wisconsin Institute of Enzyme Research, 1952-1954 4 Postdoctoral Fellow, Biochemistry Department, Nobel Institute, Stockholm, 1954-1955 6 Assistant Professor to Professor, University of Illinois, Urbana, Division of Biochemistry, Department of Chemistry, 1955-1963 7 Return to Illinois 7 Structure-Function Studies of Protein Families 7 Research on Aldolase 8 Early Studies of RNA Transcription Regulation 9 Guggenheim Fellow, Stanford University, 1962-1963 11 Professor, Departments of Biochemistry and Genetics University of Washington, 1965-1969 12 II CHAIRMAN, DEPARTMENT OF BIOCHEMISTRY AND BIOPHYSICS, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, 1968-1982 15 Dr. Rutter 's Recruitment 15 Basic Science at UCSF 19 Before Dr. Rutter 's Arrival 19 Recognizing the Need for a Molecular Approach 20 The Department of Biochemistry and Biophysics 21 Impediments to Recruiting a Chairman 21 Opportunities to Develop the Department 23 Previously Appointed Faculty Members 25 Hiring New Faculty Members 26 Negotiating for Contiguous Space 27 Faculty Recruitment 28 Policy Regarding Joint Appointments 30 A Molecular Approach 31 The Basic Science Departments: Collective Action 32 Consolidating the Department 33 Biomathematics and Crystallography 35 Recruitment 38 Strategic Sense and "Taste" in Science 39 The Department's Collaborative Approach 41 Choh Hao Li and the Hormone Research Laboratory 43 Characteristics of the Laboratory 43 Li as a Personality 44 More on X-ray Crystallography 46 Genetics in the Department and at Berkeley 46 Yeast, Drosophila. and Nematode Genetics 49 The Influence of European Molecular Biology Laboratories 51 European Models for the Department 53 The Biotechnology Industry 54 Intellectual Property and Venture Capital 54 European Models of Funding Science 55 Biological Information Becomes Applicable 58 Framing Biological Questions in Mechanistic Terms 60 Teaching 61 Initial Subordinant Role in the Department 61 W. J. Rutter as Teacher 62 Using Research Labs as Teaching Labs 63 Teaching Medical Students 64 The Graduate Curriculum at UCSF 65 The Department's Enterprise System 67 More on the Department 70 A Cooperative, Interactive Approach 71 The Importance of Contiguous Space 73 Fostering the Biological Sciences in the School of Medicine 74 Money, Space and Growth Problems at UCSF 77 Efforts to Develop the Basic Sciences: PIBS and the "Fifth School" 81 III RESEARCH IN THE MOLECULAR SCIENCES 84 Fundamental Scientific and Technology Developments in Genetics 84 Bacteriophage 84 Restriction Enzymes 85 Recombinant DNA Technology 86 Networking in Science 88 Sequencing Techniques 89 Hybridization Techniques 90 Research in the Rutter Laboratory in the 1970s 91 Transcription Enzymes and Pancreatic Differentiation 91 Cloning Methodologies 92 The Cohen-Boyer Experiments 92 Decision to Clone the Rat Gene for Insulin 94 Gordon M. Tomkins 95 Illness and Death 97 The Asilomar Conference on Recombinant DNA, February 1975 99 The Birth of the Biotechnology Industry 101 Genentech 101 Problems at UCSF Associated with Commercialization 102 Dealing as Chairman with Departmental Issues 106 The Safety Issue 10 7 The Rat Insulin Gene Project 108 Strategy and Goals 108 Dr. Rutter 's Background in Developmental Mechanisms 109 Strategy for Obtaining Islet Cells HO Competition 111 The Players at UCSF 113 More on the Problem of Obtaining Islet Cells 115 A Method for Controlling RNase Activity 117 The Ingredients of Success 118 Genentech's Approach to the Insulin Gene 120 The NIH Guidelines for Recombinant DNA Research 120 The Rat Insulin Gene Project (cont'd.) 121 Studies of Pancreatic Differentiation 121 Key Laboratory Personnel 123 Individual and Laboratory Styles 124 Vectorology 126 The P3 Laboratory 128 Repeating the Gene Cloning 132 Destruction of the Insulin Clones 133 Seeking a Source of Insulin 134 Isolating the Insulin Message 135 Howard Goodman and His Laboratory 137 Controversy over the Use of pBR322 138 The Press Conference at UCSF, May 23, 1977 143 Commercial Prospects 143 Targeting Human Insulin 144 Debate about Regulation of Recombinant DNA Research 145 Senate Hearing on Recombinant DNA Technology, November 1977 146 The Cloning Race 148 The Smithsonian Article and the NIH Guidelines 150 Weighing the Scientific Rewards 152 More on the Senate Hearing 154 Translational Fidelity, Risk/Benefit, and Recombinant DNA Vaccines 158 Hepatitis B Vaccine 159 The Rat Insulin Gene Project: Context 161 Constructing Safe Vectors 161 Departmental Tensions 162 Genentech at UCSF 163 Transference of Intellectual Property Rights to Genentech 164 More
Recommended publications
  • Beyond Darwin: Evolvability and the Generation of Novelty Marc Kirschner
    Kirschner M BMC Biology 2013, 11:110 http://www.biomedcentral.com/1741-7007/11/110 INTERVIEW Open Access Beyond Darwin: evolvability and the generation of novelty Marc Kirschner Marc Kirschner graduated in biochemistry from North- western University, moving to Berkeley for his doctoral research and with positions at Berkeley, Oxford Univer- sity and Princeton before he took a professorship at Uni- versity of California San Francisco where with Andrew Murray he did seminal research on the control of the cell cycle in Xenopus egg extracts that led to the discov- ery of how cyclin drives the cell cycle, and with Tim Mitchison on the dynamic instability of microtubules. In 1993 he moved to Harvard where in 2003 he became the founding Chair of the HMS Department of Systems Biology and was named the John Franklin Enders Uni- versity Professor in 2009. The two books he wrote with John Gerhart, Cells, Embryos and Evolution (Blackwell, 1997) and The Plausibility of Life: Resolving Darwin’sDi- lemma (Yale University Press, 2005), reflect his deep and longstanding interest in how biological systems evolve. Here he gives his view of the evolution of evolvability and its profound importance for understanding and ap- plying biology. What is evolvability - how would you define it? Marc Kirschner In some sort of tautological way evolvability is simply the capacity of a system to evolve. But more than that, in a Darwinian sense it speaks to both the amount of effectively what I mean is that if you make random variation that is subject to selection, and the nature of changes in mechanical systems they inevitably either that variation.
    [Show full text]
  • Information-Seeking Behavior in Complementary and Alternative Medicine (CAM): an Online Survey of Faculty at a Health Sciences Campus*
    Information-seeking behavior in complementary and alternative medicine (CAM): an online survey of faculty at a health sciences campus* By David J. Owen, M.L.S., Ph.D. [email protected] Education Coordinator, Basic Sciences Min-Lin E. Fang, M.L.I.S. [email protected] Information Services Librarian Kalmanovitz Library and Center for Knowledge Management University of California, San Francisco San Francisco, California 94143-0840 Background: The amount of reliable information available for complementary and alternative medicine (CAM) is limited, and few authoritative resources are available. Objective: The objective is to investigate the information-seeking behavior of health professionals seeking CAM information. Methods: Data were gathered using a Web-based questionnaire made available to health sciences faculty af®liated with the University of California, San Francisco. Results: The areas of greatest interest were herbal medicine (67%), relaxation exercises (53%), and acupuncture (52%). About half the respondents perceived their CAM searches as being only partially successful. Eighty-two percent rated MEDLINE as a useful resource, 46% personal contacts with colleagues, 46% the Web, 40% journals, and 20% textbooks. Books and databases most frequently cited as useful had information about herbs. The largest group of respondents was in internal medicine (26%), though 15% identi®ed their specialties as psychiatry, psychology, behavioral medicine, or addiction medicine. There was no correlation between specialty and patterns of information- seeking behavior. Sixty-six percent expressed an interest in learning more about CAM resources. Conclusions: Health professionals are frequently unable to locate the CAM information they need, and the majority have little knowledge of existing CAM resources, relying instead on MEDLINE.
    [Show full text]
  • University of California, Office of the President Records, 1914-1958
    http://oac.cdlib.org/findaid/ark:/13030/kt0489p7t8 No online items Guide to the University of California, Office of the President Records, 1914-1958 Processed by The Bancroft Library staff. The Bancroft Library. University of California, Berkeley Berkeley, California, 94720-6000 Phone: (510) 642-6481 Fax: (510) 642-7589 Email: [email protected] URL: http://bancroft.berkeley.edu © 2003 The Regents of the University of California. All rights reserved. Guide to the University of CU-5, Series 2 1 California, Office of the President Records, 1914-1958 Guide to the University of California, Office of the President Records, 1914-1958 Collection number: CU-5, Series 2 The Bancroft Library University of California, Berkeley Berkeley, California Contact Information: The Bancroft Library. University of California, Berkeley Berkeley, California, 94720-6000 Phone: (510) 642-6481 Fax: (510) 642-7589 Email: [email protected] URL: http://bancroft.berkeley.edu Processed by: The Bancroft Library staff Date Completed: September 2003 Encoded by: James Lake © 2003 The Regents of the University of California. All rights reserved. Collection Summary Collection Title: University of California, Office of the President records, Date (inclusive): 1914-1958 Collection Number: CU-5, Series 2 Creator: University of California (System). Office of the President Extent: 612.5 linear ft. Repository: The Bancroft Library. Berkeley, California 94720-6000 Physical Location: For current information on the location of these materials, please consult the Library's online catalog. Languages Represented: English Access The collection is open for research, although certain kinds of confidential information may be withheld if found. Publication Rights Copyright has not been assigned to The Bancroft Library.
    [Show full text]
  • The Drosophila MCPH1-B Isoform Is a Substrate of the APC E3 Ubiquitin Ligase Complex
    ß 2014. Published by The Company of Biologists Ltd | Biology Open (2014) 3, 669–676 doi:10.1242/bio.20148318 RESEARCH ARTICLE The Drosophila MCPH1-B isoform is a substrate of the APCCdh1 E3 ubiquitin ligase complex Sarah G. Hainline`, Jamie L. Rickmyre`,*, Leif R. Neitzel, Laura A. Lee§ and Ethan Lee§ ABSTRACT and two primary co-activators, Cdc20 and Cdh1 (Kulkarni et al., 2013). Destruction of APC substrates is required in eukaryotes for The Anaphase-Promoting Complex (APC) is a multi-subunit E3 the initiation of anaphase and exit from mitosis. Cdc20 associates ubiquitin ligase that coordinates progression through the cell cycle by with the APC in early mitosis, leading to the destruction of temporally and spatially promoting the degradation of key proteins. proteins that control the onset of anaphase, whereas Cdh1 Many of these targeted proteins have been shown to play important promotes degradation of APC substrates that control late mitosis roles in regulating orderly progression through the cell cycle. Using and the following G1 phase. These co-activators provide APC a previously described Drosophila in vitro expression cloning substrate specificity by facilitating the recognition of specific approach, we screened for new substrates of the APC in Xenopus destruction motifs (e.g. degrons) such as the D-box (RxxLxxxxN) egg extract and identified Drosophila MCPH1 (dMCPH1), a protein or KEN box (Lys–Glu–Asn) (King et al., 1996; Min and Lindon, encoded by the homolog of a causative gene for autosomal recessive 2012; Pfleger and Kirschner, 2000). Mutations of these motifs primary microcephaly in humans. The dMCPH1-B splice form, but not block the recognition of the protein by the APC, preventing their the dMCPH1-C splice form, undergoes robust degradation in APC-mediated destruction.
    [Show full text]
  • The Next Generation of Biomedical and Behavioral Sciences Researchers: Breaking Through
    THE NATIONAL ACADEMIES PRESS This PDF is available at http://nap.edu/25008 SHARE The Next Generation of Biomedical and Behavioral Sciences Researchers: Breaking Through DETAILS 162 pages | 6 x 9 | PAPERBACK ISBN 978-0-309-47137-4 | DOI 10.17226/25008 CONTRIBUTORS GET THIS BOOK Committee on the Next Generation Initiative; Board on Higher Education and Workforce; Policy and Global Affairs; National Academies of Sciences, Engineering, and Medicine FIND RELATED TITLES Visit the National Academies Press at NAP.edu and login or register to get: – Access to free PDF downloads of thousands of scientific reports – 10% off the price of print titles – Email or social media notifications of new titles related to your interests – Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. (Request Permission) Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Copyright © National Academy of Sciences. All rights reserved. The Next Generation of Biomedical and Behavioral Sciences Researchers: Breaking Through THE NEXT GENERATION OF BIOMEDICAL AND BEHAVIORAL SCIENCES RESEARCHERS: BREAKING THROUGH Committee on the Next Generation Initiative Board on Higher Education and Workforce Policy and Global Affairs A Consensus Study Report of PREPUBLICATION COPY—UNEDITED PROOFS Copyright National Academy of Sciences. All rights reserved. The Next Generation of Biomedical and Behavioral Sciences Researchers: Breaking Through THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001 This activity was supported by contracts between the National Academy of Sciences and The National Institutes of Health (#HHSN263201200074I, Order No.
    [Show full text]
  • Regional Oral History Office University of California the Bancroft Library Berkeley, California
    Regional Oral History Office University of California The Bancroft Library Berkeley, California Daniel Koshland, Jr. Retrospective Oral History Project: Bruce Alberts Interviews conducted by Sally Smith Hughes in 2012 Copyright © 2014 by The Regents of the University of California ii Since 1954 the Regional Oral History Office has been interviewing leading participants in or well-placed witnesses to major events in the development of Northern California, the West, and the nation. Oral History is a method of collecting historical information through tape-recorded interviews between a narrator with firsthand knowledge of historically significant events and a well-informed interviewer, with the goal of preserving substantive additions to the historical record. The tape recording is transcribed, lightly edited for continuity and clarity, and reviewed by the interviewee. The corrected manuscript is bound with photographs and illustrative materials and placed in The Bancroft Library at the University of California, Berkeley, and in other research collections for scholarly use. Because it is primary material, oral history is not intended to present the final, verified, or complete narrative of events. It is a spoken account, offered by the interviewee in response to questioning, and as such it is reflective, partisan, deeply involved, and irreplaceable. ********************************* All uses of this manuscript are covered by a legal agreement between The Regents of the University of California and Bruce Alberts on March 21, 2014. The manuscript is thereby made available for research purposes. All literary rights in the manuscript, including the right to publish, are reserved to The Bancroft Library of the University of California, Berkeley. Excerpts up to 1000 words from this interview may be quoted for publication without seeking permission as long as the use is non-commercial and properly cited.
    [Show full text]
  • 2011 Annual Report
    Mission 02 Who we are, What we do 03 Reports Chairman's Report 04 Executive Director's Report 06 Garvan Research Foundation Chairman's Report 08 Professor John Mattick 10 Garvan at a Glance Organisation Chart 13 Patent Portfolio by Category 14 Scientific Publications 14 Philanthropic Support 14 Staff Profile 15 Operating Income 15 Peer Reviewed Grant Income 15 Research Collaborations 17 Research Highlights 19 Research Programs & Initiatives Cancer Program 20 The Kinghorn Cancer Centre 28 Diabetes & Obesity Program 30 Diabetes Vaccine Development Centre 36 Immunology Program 38 Neuroscience Program 44 Professor Peter Croucher 50 Osteoporosis & Bone Biology 52 Core Research Facilities 57 Management Highlights 58 Business Development 59 Garvan Community Life Governors 61 Partners for the Future 61 Volunteers 62 Garvan Supporters 62 Garvan Gala Supporters 65 Bequests 65 Governance Garvan Institute 67 Garvan Research Foundation 70 Publications 73 Financial Highlights Income Statement 85 Balance Sheet 86 Garvan Research Foundation Statement of Funds 87 Garvan's mission is to make significant contributions to medical research that will change the directions of science and medicine and have major impacts on human health. Garvan strives to enhance and develop research programs that combine fundamental science with strong clinical interactions. The Garvan Institute of Medical Research Significant breakthroughs have been is a world leader in its field, pioneering achieved by Garvan scientists in the study into some of the most widespread understanding and treatment of diseases diseases affecting our community today. such as: Research at Garvan is focused upon understanding the role of genes in health _ Cancer and disease as the basis for developing _ Diabetes and obesity future cures.
    [Show full text]
  • Joint Meeting: Committees on Finance and Compensation
    The Regents of the University of California COMMITTEE ON FINANCE COMMITTEE ON COMPENSATION July 15, 2009 The Committees on Finance and Compensation met jointly on the above date at UCSF–Mission Bay Community Center, San Francisco. Members present: Representing the Committee on Finance: Regents Bernal, Garamendi, Island, Kozberg, Lozano, Makarechian, Schilling, Varner, and Wachter; Ex officio members Blum, Gould, and Yudof; Advisory member Croughan; Staff Advisors Abeyta and Martinez Representing the Committee on Compensation: Regents Johnson, Kozberg, Lozano, Stovitz, and Varner; Ex officio members Blum, Gould, and Yudof; Advisory members Croughan and Hime In attendance: Regents De La Peña, Kieffer, Lansing, Marcus, Nunn Gorman, Reiss, Ruiz, and Zettel, Regent-designate Cheng, Faculty Representative Powell, Secretary and Chief of Staff Griffiths, Associate Secretary Shaw, General Counsel Robinson, Chief Investment Officer Berggren, Chief Compliance and Audit Officer Vacca, Interim Provost Pitts, Executive Vice Presidents Lapp and Taylor, Senior Vice Presidents Dooley and Stobo, Vice Presidents Beckwith, Broome, Duckett, Lenz, and Sakaki, Chancellors Birgeneau, Bishop, Block, Blumenthal, Drake, Fox, Kang, Vanderhoef, White, and Yang, and Recording Secretary Johns The meeting convened at 10:20 a.m. with Committee on Finance Chair Lozano presiding. 1. AMENDMENT OF STANDING ORDER 100.4 – DUTIES OF THE PRESIDENT The President recommended that the Committees on Finance and Compensation recommend that: A. Pursuant to Bylaw 7.3, the requirements
    [Show full text]
  • EMBL in Australia EMBL in Italy Friday,Dedicated 9 June To2017 Riccardo Cortese 13:30 –19:00Friday 5 May 2017, 10:30-19:00
    EMBL in Australia EMBL in Italy Friday,Dedicated 9 June to2017 Riccardo Cortese 13:30 –19:00Friday 5 May 2017, 10:30-19:00 Venue: The Garvan Institute of Medical Research Venue: TIGEM (Auditorium) in Pozzuoli, near Naples John Shine Meeting Room, Level 6 of The Kinghorn Via Campi Flegrei 34, 80078 Cancer Centre, 370 Victoria Street, Darlinghurst [email protected] PROGRAMME 10:30-11:00 Welcome networking 11:00-11:30 In memory of Riccardo Cortese Friday 9 June Phil Avner, Head, EMBL Monterotondo Andrea Ballabio, Scientific Director, TIGEM 13:30–14:00 Welcome Coffee Alfredo Nicosia, CSO & Co-founder, Okairos 14:00–15:00 EMBL and EMBL Australia Partnership 11:30-12:30 Research at EMBL Phil Avner,John Head, Mattick EMBL Monterotondo Jamie Hackett,Executive Group Director, Leader, Garvan EMBL Institute Monterotondo Paul Heppenstall,Silke Schumacher Group Leader, EMBL Monterotondo DiscussionDirector International Relations, EMBL, Heidelberg James Whisstock 12:30-13:30 ResearchScientific at TIGEM Head, EMBL Australia Partnership GracianaNHMRC Diez Roux,Senior ChiefPrincipal Scientific Research Officer, Fellow, TIGEM Monash University Andrea Ballabio, Scientific Director, TIGEM Katharina Gaus Antonella De Matteis, Cell Biology programme coordinator, TIGEM Head, EMBL Australia Node in Single Molecule Science Carmine Settembre, Assistant investigator, TIGEM NHMRC Senior Research Fellow, University of New South Wales Diego Medina, Head, High Content Screening Facility, TIGEM 15:00–15:30 Coffee 13:30-15:00 Lunch and tour of TIGEM labs 15:30–16:50 EMBL Alumni Research 15:00-16:00 Resources in Italy Marco Foiani,Sean O’ Scientific Donoghue Director, IFOM FedericoGroup Caligaris-Cappio, Leader and Senior Scientific Faculty Director, Member, AIRC Garvan Institute Lucia Faccio,Chief Executive Director Scienceof Business Leader, Development, CSIRO Telethon Mirana Ramialison 16:00-16:30 CoffeeGroup Leader, Australian Regenerative Medicine Institute, Monash University 16:30-17:30 ResearchMichael of EMBL Parker alumni GennaroDirector, Ciliberto, St.
    [Show full text]
  • Timeline Code Dnai Site Guide
    DNAi Site Guide 1 DNAi Site Guide Timeline Pre 1920’s Johann Gregor Mendel, Friedrich Miescher, Carl Erich Correns, Hugo De Vries, Erich Von Tschermak- Seysenegg, Thomas Hunt Morgan 1920-49 Hermann Muller, Barbara McClintock, George Wells Beadle, Edward Lawrie Tatum, Joshua Lederberg, Oswald Theodore Avery 1950-54 Erwin Chargaff, Rosalind Elsie Franklin, Martha Chase, Alfred Day Hershey, Linus Pauling, James Dewey Watson, Francis Harry Compton Crick, Seymour Benzer 1955-59 Francis Harry Compton Crick, Paul Charles Zamecnik, Mahlon Hoagland, Matthew Stanley Meselson, Franklin William Stahl, Arthur Kornberg 1960’s Sydney Brenner, Marshall Warren Nirenberg, François Jacob, Jacques Lucien Monod, Roy John Britten 1970’s David Baltimore, Howard Martin Temin, Stanley Norman Cohen, Herbert W. Boyer, Richard John Roberts, Phillip Allen Sharp, Roger Kornberg, Frederick Sanger 1980’s Christiane Nüsslein-Volhard, Eric Francis Wieschaus, Kary Mullis, Thomas Robert Cech, Sidney Altman, Mario Renato Capecchi 1990-2000 Mary-Claire King, Stephen P.A. Fodor, Patrick Henry Brown, John Craig Venter Francis Collins, John Sulston Code Finding the structure Problem What is the structure of DNA? DNAi Site Guide 2 Players Erwin Chargaff, Rosalind Franklin, Linus Pauling, James Watson and Francis Crick, Maurice Wilkins Pieces of the puzzle Wilkins' X-ray, Pauling's triple helix, Franklin's X-ray, Watson's base pairing, Chargaff's ratios Putting it together DNA is a double-stranded helix. Copying the code Problem How is DNA copied? Players James Watson and Francis Crick, Sydney Brenner, François Jacob, Matthew Meselson, Arthur Kornberg Pieces of the puzzle The Central Dogma, Semi-conservative replication Models of DNA replication, The RNA experiment, DNA synthesis Putting it together DNA is used as a template for copying information.
    [Show full text]
  • Synthetic Insulin
    1 Invent or Discover: the art of useful science www.alanrwalker.com Synthetic insulin ‘As if science was too serious a business to be left to grown-ups.’ (François Jacob) Squeezed up against the southern slopes of the San Gabriel Mountains, by Los Angeles, lies the town of Duarte with its City of Hope National Medical Center. The hospital was founded in 1928 as a tented sanatorium to care for patients with tuberculosis and over the next fifty years it evolved into a world famous location for research and treatment of cancer. In 1979 one of the researchers there, Keiichi Itakura, applied for a patent concerning ‘recombinant DNA’. Few of his colleagues would have appreciated what he wanted, but amongst them Arthur Riggs had applied for a paired patent on ‘microbial polypeptide expression’. Within the depths of the dry legalistic texts stirred the creation of an incredible transformation in medicine and industry. Here were instructions, both specifically technical and of general application, to construct the genes responsible for human hormones such as insulin, then manufacture these hormone by using broths of bacteria. How to construct human genes? Yes, build them up them from small chemical units on the laboratory bench. Manufacture them using bacteria! Why not, the researchers would have answered? Bacteria can be tricked into producing a protein based on the coding from a gene that has been inserted into them; a synthetic human gene for example. Since bacteria reproduce extremely rapidly and can be grown in industrial vats using simple nutrients, they form vast numbers of tiny factories to pump out the hormone.
    [Show full text]
  • Fiscal Year 2011
    UNIVERSITY OF PITTSBURGH Financial Disclosure Report Response to the Requirements of Public School Code of 1949 Amended by Act 61 of 2008 Section 25, 2004-D (A) – (D) Volume II For the Fiscal Year Ended June 30, 2011 UNIVERSITY OF PITTSBURGH Financial Disclosure Report Purchase of Services Contracts Purchase of Goods Contracts Notes and Definitions The following tables provide the required disclosures for purchase of services and purchase of goods contracts. The University’s Accounts Payable System does not include data enabling the distinction between purchases of goods and services. Thus, a single schedule is provided that includes both goods and services. Purchases are categorized in the University’s Accounts Payable System in one of the following categories: Facility Alterations Facility Operating Costs Insurance Library Acquisitions Mail Printing/Publishing Professional Memberships Professional Services Purchases for Resale Routine Maintenance Space Rental Supplies/Equipment Telephone Utilities Each entry provides the category into which the purchase falls, the name and address of the vendor, and the amount of purchase. There is no more than one entry per vendor for a single category within a responsibility center. Disclosures for defined projects or programs are included in the disclosure for the units in which they are administered. Purchases of goods and services in the Disclosure Report include those which equal or exceed $1,000 for each vendor from Operating, Auxiliary, and Non-Auxiliary funding sources. UNIVERSITY OF PITTSBURGH
    [Show full text]